REGENXBIO Inc. (RGNX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -76.19M | -52.29M | -55.96M | -49.34M | 33.63M | -31.62M | -40.55M | -45.5M | -55.45M | -40.76M | -49.41M | -47.32M |
| Operating CF Margin % | -1191.71% | -172.36% | -188.21% | -231.01% | 37.78% | -149.07% | -167.58% | -204.07% | -354.98% | -183.5% | -170.88% | -236.88% |
| Operating CF Growth % | -326.55% | -65.35% | -38.01% | -8.45% | 160.64% | 22.41% | 17.93% | 3.86% | 31.47% | -3.53% | 2.08% | 23.36% |
| Net Income | -90.05M | -67.15M | -61.94M | -70.87M | 6.08M | -51.19M | -59.6M | -52.99M | -63.33M | -62.89M | -61.87M | -72.06M |
| Depreciation & Amortization | 3.86M | 3.87M | 3.89M | 3.9M | 3.96M | 4.02M | 3.96M | 4.05M | 4.18M | 4.33M | 4.37M | 4.43M |
| Stock-Based Compensation | 0 | 8.38M | 9M | 8.65M | 8.54M | 9.54M | 9.88M | 9.44M | 9.6M | 8.34M | 10.22M | 10.5M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 11.51M | 4.41M | 3.47M | 1.43M | -1.36M | -5.66M | -866K | -1.96M | 2.25M | 233K | -1.51M | -325K |
| Working Capital Changes | -1.5M | -1.8M | -10.37M | 7.54M | 16.41M | 11.66M | 6.07M | -4.04M | -8.16M | 9.22M | -623K | 10.13M |
| Change in Receivables | 18.25M | -561K | -6.31M | -2.36M | 1.57M | 8.13M | -710K | -6.89M | 9.18M | 3.37M | -6.54M | -2.39M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 349K | -1.86M | 694K | 2.53M | -3.65M | 3.04M | 3.12M | -14.91M | 8.46M | 1.22M | 10.1M | -11.01M |
| Cash from Investing | 70.59M | 37.54M | 42.29M | -140.44M | 44.74M | 40.27M | 50.26M | -268K | 13.18M | 33.97M | 38.66M | 55.22M |
| Capital Expenditures | -1.24M | -508K | -491K | -391K | -1.02M | -1.08M | -326K | -474K | -557K | -1.13M | -1.44M | -2.58M |
| CapEx % of Revenue | 19.32% | 1.67% | 1.65% | 1.83% | 1.15% | 5.09% | 1.35% | 2.13% | 3.57% | 5.07% | 4.98% | 12.9% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -13.64M | -9.58M | -7.08M | 139.23M | -5.79M | -7.74M | -10.86M | -9.45M | 120.72M | -11.96M | -4.8M | -9.16M |
| Debt Issued (Net) | 0 | 0 | -144.53M | 144.53M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 564K | -144.43M | 145.16M | -34K | 307K | 0 | 495K | -249K | 132.01M | -210K | 6.12M | 749K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 307K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -14.2M | 134.84M | -7.72M | -5.26M | -6.1M | -7.74M | -11.35M | -9.2M | -11.29M | -11.75M | -10.92M | -9.91M |
| Net Change in Cash | -19.24M | -24.34M | -20.76M | -50.55M | 72.58M | 909K | -1.15M | -55.21M | 78.45M | -18.52M | -15.55M | -1.49M |
| Free Cash Flow | -77.42M | -52.8M | -56.45M | -49.73M | 32.6M | -32.7M | -40.88M | -45.97M | -56.01M | -41.89M | -50.85M | -49.9M |
| FCF Margin % | -1211.03% | -174.04% | -189.86% | -232.84% | 36.63% | -154.16% | -168.93% | -206.19% | -358.55% | -188.57% | -175.85% | -249.78% |
| FCF Growth % | -337.45% | -61.45% | -38.11% | -8.18% | 158.21% | 21.92% | 19.61% | 7.87% | 34.67% | 6.59% | 8.4% | 29.71% |
| FCF per Share | -1.48 | -1.02 | -1.09 | -0.97 | 0.63 | -0.64 | -0.80 | -0.91 | -1.22 | -0.95 | -1.16 | -1.15 |
| FCF Conversion (FCF/Net Income) | 0.85x | 0.78x | 0.90x | 0.70x | 5.53x | 0.62x | 0.68x | 0.86x | 0.88x | 0.65x | 0.80x | 0.66x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |